Literature DB >> 3877732

Inhibition of rat cervical epithelial cell growth by heparin and its reversal by EGF.

T C Wright, T V Johnstone, J J Castellot, M J Karnovsky.   

Abstract

The effects of heparin on the in vitro growth of rat cervical epithelial cells were examined. Heparin was found to inhibit in a dose dependent fashion the log-phase growth of rat cervical epithelial cells (RCEC) grown in the absence of medium supplements. An inhibition of growth is observed at concentrations as low as 500 ng/ml and 50% inhibition of growth occurs at a concentration of 5 micrograms/ml. The growth inhibitory activity of heparin is independent of anticoagulant activity since three separate non-anticoagulant preparations of heparin all inhibit growth. Other glycosaminoglycans including chondroitin 4-sulfate, chondroitin 6-sulfate, dermatan sulfate, hyaluronic acid, and keratin sulfate do not inhibit the growth of rat cervical epithelial cells. The ability of heparin to inhibit the log-phase growth of rat cervical epithelial cells is dependent on the composition of the medium in which the cells are grown. The addition of greater than or equal to 7.5 ng/ml epidermal growth factor to epithelial cultures blocks the growth inhibitory activity of heparin. These results suggest that components of the extracellular matrix modulate the growth responses of epithelial cells and may be important in regulating cellular proliferation in normal and pathological states.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3877732     DOI: 10.1002/jcp.1041250320

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  18 in total

1.  Inhibition of vein graft intimal proliferative lesions in the rat by heparin.

Authors:  G M Hirsch; M J Karnovsky
Journal:  Am J Pathol       Date:  1991-09       Impact factor: 4.307

2.  Carboxymethyl benzylamide dextrans inhibit breast cell growth.

Authors:  R Bagheri-Yarmand; P Bittoun; J Champion; D Letourneur; J Jozefonvicz; S Fermandjian; M Crépin
Journal:  In Vitro Cell Dev Biol Anim       Date:  1994-12       Impact factor: 2.416

3.  Control of smooth muscle cell growth by components of the extracellular matrix: autocrine role for thrombospondin.

Authors:  R A Majack; S C Cook; P Bornstein
Journal:  Proc Natl Acad Sci U S A       Date:  1986-12       Impact factor: 11.205

4.  Effects of glycosaminoglycans and extracellular matrix components on metastatic rat rhabdomyosarcoma tumor and myoblast cell proliferation.

Authors:  F Redini; E Moczar; M F Poupon
Journal:  Clin Exp Metastasis       Date:  1990 Sep-Oct       Impact factor: 5.150

5.  Effect of carboxyl-reduced heparin on the growth inhibition of bovine pulmonary artery smooth muscle cells.

Authors:  Hari G Garg; Hicham Mrabat; Lunyin Yu; Craig Freeman; Boyangzi Li; Fuming Zhang; Robert J Linhardt; Charles A Hales
Journal:  Carbohydr Res       Date:  2010-03-21       Impact factor: 2.104

6.  Heparin inhibits c-fos and c-myc mRNA expression in vascular smooth muscle cells.

Authors:  L A Pukac; J J Castellot; T C Wright; B L Caleb; M J Karnovsky
Journal:  Cell Regul       Date:  1990-04

7.  Binding and endocytosis of heparin-gold conjugates by the fenestrated endothelium of the rat choriocapillaris.

Authors:  R M Pino
Journal:  Cell Tissue Res       Date:  1987-11       Impact factor: 5.249

8.  In vitro stimulation of human endothelial cells by derivatized dextrans.

Authors:  D Letourneur; J Champion; F Slaoui; J Jozefonvicz
Journal:  In Vitro Cell Dev Biol       Date:  1993-01

9.  Heparin and hormonal regulation of mRNA synthesis and abundance of autocrine growth factors: relevance to clonal growth of tumors.

Authors:  I Zvibel; E Halay; L M Reid
Journal:  Mol Cell Biol       Date:  1991-01       Impact factor: 4.272

10.  Heparin alters epidermal growth factor metabolism in cultured rat glomerular epithelial cells.

Authors:  S Adler
Journal:  Am J Pathol       Date:  1991-07       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.